Analysts Anticipate Xenon Pharmaceuticals Inc. (NASDAQ:XENE) to Post -$0.47 EPS
Brokerages predict that Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) will post ($0.47) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Xenon Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.52) and the highest is ($0.34). Xenon Pharmaceuticals reported earnings per share of ($0.51) during […]